Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

158.97 -2.28 (-1.41%)
Official Closing Price Updated: 7:00 PM EDT, Aug 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,607,147
Open 161.05
Bid (Size) 157.21 (1)
Ask (Size) 159.30 (3)
Prev. Close 161.25
Today's Range 158.94 - 161.48
52wk Range 143.13 - 175.97
Shares Outstanding 2,628,679,824
Dividend Yield 2.99%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Alzheimer’s Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D Activities
EQNX::TICKER_START (NYSE:ANVS),(NYSE:MRK),(NASDAQ:SNY),(NYSE:JNJ),(NYSE:NVS) EQNX::TICKER_END 
Via FinancialNewsMedia
3 Dividend Growth Stocks to Accumulate on Dips: August Edition
These three dividend growth stocks are among the best options for long-term investors seeking reliable total returns in this current market. 
Via InvestorPlace

Performance

YTD
-0.63%
-0.63%
1 Month
+9.27%
+9.27%
3 Month
+6.89%
+6.89%
6 Month
+0.58%
+0.58%
1 Year
-8.16%
-8.16%

More News

Read More
The Market's Excessive Recession Fears
Via Talk Markets
Topics Economy
Exposures Economy
Large Cap Biopharma And Healthcare, A Port In A Storm
Via Talk Markets
Looking At Johnson & Johnson's Recent Unusual Options Activity
Via Benzinga
Comparative Study: Johnson & Johnson And Industry Competitors In Pharmaceuticals Industry
Via Benzinga
A Closer Look at 14 Analyst Recommendations For Johnson & Johnson
Via Benzinga
Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D Activities
From FN Media Group LLC
Via GlobeNewswire
3 Defensive Stocks Weathering the Market Storm
Via MarketBeat
Topics Economy Stocks
Exposures Economy US Equities
Johnson & Johnson Unusual Options Activity For July 29
Via Benzinga
The S&P 500 Had Its Worst July in a Decade. Should You Really Buy Stocks Now?
Via The Motley Fool
Topics Stocks
Exposures US Equities
Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now
Via The Motley Fool
Forget Johnson & Johnson: Another Healthcare Giant Is a Much Better Bet for Growth
Via The Motley Fool
Bargain-Hunters Paradise: 7 Value Stocks That Are Too Cheap to Ignore
Via InvestorPlace
7 Leading MedTech Stocks for Next-Gen Health Solutions
Via InvestorPlace
Kazia Therapeutics Stock: Is KZIA a Buyout Candidate in the Making?
Via InvestorPlace
Bristol Myers, Johnson & Johnson, AbbVie, AstraZeneca Expect Minimal Impact From Upcoming Medicare Price Negotiations
Via Benzinga
Q3’s Rising Stars: 3 Dow Stocks for Your Must-Watch List
Via InvestorPlace
Topics Stocks
Exposures US Equities
Top 2 Cheap Healthcare Stocks to Buy as Sector Outperforms
Via MarketBeat
Topics ETFs
Johnson & Johnson to Participate in the 2024 Wells Fargo Healthcare Conference
From Johnson & Johnson
Via Business Wire
Stocks Going Ex Dividend In August 2024
Via Talk Markets
7 Long-Term Stocks to Buy on the Dip: July 2024
Via InvestorPlace
Could Johnson & Johnson's Troubles With Talc Lawsuits Finally Be Coming to an End?
Via The Motley Fool
Topics Lawsuit
Exposures Financial Legal
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Courts, Congress Likely to Stand in Way of J&J’s Third Texas Two-Step Plan
From Beasley Allen Law Firm
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.